siRNA therapy lowers triglycerides in patients with unusual problem

.INVESTIGATION EMPHASIZE.19 September 2024.

Plozasiran reduced triglyceride levels through 80% and also reduced the danger of pancreatitis in patients with consistent chylomicronemia, along with or without a genetic medical diagnosis.